• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旨在减少医院环境中产碳青霉烯酶肠杆菌科细菌的抗疫措施的有效性。

Effectiveness of Antiepidemic Measures Aimed to Reduce Carbapenemase-Producing Enterobacteriaceae in the Hospital Environment.

作者信息

Pawlak Maria, Lewtak Katarzyna, Nitsch-Osuch Aneta

机构信息

Department of Social Medicine and Public Health, Medical University of Warsaw, Faculty of Medicine, Warsaw, Poland.

出版信息

Can J Infect Dis Med Microbiol. 2022 Apr 26;2022:9299258. doi: 10.1155/2022/9299258. eCollection 2022.

DOI:10.1155/2022/9299258
PMID:35528804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9072043/
Abstract

PURPOSE

The objective of this study was to evaluate the effectiveness of hospital-based antiepidemic measures aimed at limiting the spread of symptomatic infections and colonization with carbapenem-resistant (CPE), mainly NDM-producing , with particular emphasis on microbiological screening tests.

METHODS

This retrospective study was based on data from 168 hospitals under the supervision of the Provincial Sanitary and Epidemiological Station in Warsaw, Poland, in 2016-2017. Analysis of the effectiveness of antiepidemic procedures focused on the type of implemented antiepidemic procedures, the number of microbiological screening tests per year, the geographic location of the hospitals (inside or outside Warsaw), the timing of the screening tests (on admission to hospital or 48 hours later), and the results of the screening tests.

RESULTS

Rates of proper isolation of patients infected or colonized with an alarm pathogen including NDM-producing increased from 38.0% in 2016 to 49.5% in 2017 ( > 0.05). The number of screening tests performed increased by 88% from 68319 in 2016 to 128373 in 2017. The number of epidemic outbreaks of symptomatic infections caused by NDM-producing decreased from 11 in 2016 to 7 in 2017 in hospitals in Warsaw, where microbiological screening tests were performed. The number of outbreaks in hospitals outside Warsaw, where the screening tests were not performed or were limited, increased from 8 in 2016 to 24 in 2017.

CONCLUSION

Screening tests increase the chance of detecting colonization by CPE. The implementation of microbiological screening decreased the risk of epidemic outbreaks of symptomatic infections caused by CPE.

摘要

目的

本研究的目的是评估以医院为基础的抗疫措施的有效性,这些措施旨在限制有症状感染的传播以及耐碳青霉烯类肠杆菌科细菌(CPE)(主要是产新德里金属β-内酰胺酶[NDM]的细菌)的定植,特别强调微生物筛查检测。

方法

这项回顾性研究基于2016 - 2017年波兰华沙省卫生和流行病学站监督下的168家医院的数据。对抗疫程序有效性的分析集中在实施的抗疫程序类型、每年微生物筛查检测的数量、医院的地理位置(华沙市内或市外)、筛查检测的时间(入院时或48小时后)以及筛查检测的结果。

结果

感染或定植有包括产NDM细菌在内的警示病原体的患者的正确隔离率从2016年的38.0%上升至2017年的49.5%(P>0.05)。进行的筛查检测数量从2016年的68319次增加了88%,至2017年的128373次。在进行微生物筛查检测的华沙医院中,由产NDM细菌引起的有症状感染的疫情暴发数量从2016年的11起降至2017年的7起。在未进行或仅进行有限筛查检测的华沙以外医院,疫情暴发数量从2元16年的8起增至2017年的24起。

结论

筛查检测增加了检测到CPE定植的机会。微生物筛查的实施降低了由CPE引起的有症状感染的疫情暴发风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/9072043/45caf8b44041/CJIDMM2022-9299258.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/9072043/d8eff2ed2bee/CJIDMM2022-9299258.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/9072043/6467e1325f0c/CJIDMM2022-9299258.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/9072043/45caf8b44041/CJIDMM2022-9299258.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/9072043/d8eff2ed2bee/CJIDMM2022-9299258.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/9072043/6467e1325f0c/CJIDMM2022-9299258.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/9072043/45caf8b44041/CJIDMM2022-9299258.003.jpg

相似文献

1
Effectiveness of Antiepidemic Measures Aimed to Reduce Carbapenemase-Producing Enterobacteriaceae in the Hospital Environment.旨在减少医院环境中产碳青霉烯酶肠杆菌科细菌的抗疫措施的有效性。
Can J Infect Dis Med Microbiol. 2022 Apr 26;2022:9299258. doi: 10.1155/2022/9299258. eCollection 2022.
2
Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Unraveled Using Whole-Genome Sequencing.应用全基因组测序技术揭示新德里金属β-内酰胺酶产生菌的医院同期暴发
Microbiol Spectr. 2022 Apr 27;10(2):e0228721. doi: 10.1128/spectrum.02287-21. Epub 2022 Mar 21.
3
An Irish outbreak of New Delhi metallo-β-lactamase (NDM)-1 carbapenemase-producing Enterobacteriaceae: increasing but unrecognized prevalence.爱尔兰新德里金属β-内酰胺酶(NDM)-1产碳青霉烯酶肠杆菌科细菌的暴发:患病率不断上升但未被认识到。
J Hosp Infect. 2016 Dec;94(4):351-357. doi: 10.1016/j.jhin.2016.08.005. Epub 2016 Aug 19.
4
Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.2014-2016 年斯洛文尼亚成功控制首例 OXA-48 和/或 NDM 碳青霉烯酶产生的肺炎克雷伯菌爆发
J Hosp Infect. 2019 Feb;101(2):142-149. doi: 10.1016/j.jhin.2018.10.022. Epub 2018 Nov 3.
5
Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.感染控制和获得产碳青霉烯酶肠杆菌科的危险因素。一项为期 5 年(2011-2016 年)的病例对照研究。
Antimicrob Resist Infect Control. 2020 Jan 17;9(1):18. doi: 10.1186/s13756-019-0668-2. eCollection 2020.
6
Epidemiology and Risk Factors of Carbapenemase-Producing Acquisition and Colonization at a Korean Hospital over 1 Year.韩国一家医院一年多来产碳青霉烯酶菌获得与定植的流行病学及危险因素
Antibiotics (Basel). 2023 Apr 14;12(4):759. doi: 10.3390/antibiotics12040759.
7
Outbreak of carbapenemase-producing Enterobacteriaceae associated with a contaminated water dispenser and sink drains in the cardiology units of a Korean hospital.韩国一家医院心内科的带污染滤水器和水槽排水管的肠杆菌科碳青霉烯酶产生菌爆发。
J Hosp Infect. 2020 Apr;104(4):476-483. doi: 10.1016/j.jhin.2019.11.015. Epub 2019 Nov 27.
8
Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).捷克医院产碳青霉烯酶大肠埃希菌和肺炎克雷伯菌分离株的患病率研究——欧洲产碳青霉烯酶肠杆菌科细菌调查(EuSCAPE)捷克部分的结果
Epidemiol Mikrobiol Imunol. 2015 Jun;64(2):87-91.
9
Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.2015 年至 2017 年间,泰国曼谷诗里拉吉医院定植患者的产多药耐药碳青霉烯酶 ST231 和 ST16 肺炎克雷伯菌的基因组和临床特征。
BMC Infect Dis. 2021 Feb 4;21(1):142. doi: 10.1186/s12879-021-05790-9.
10
Positivity of Carbapenemase-producing in Patients Following Exposure within Long-term Care Facilities in Seoul, Korea.韩国首尔长期护理机构暴露患者中产碳青霉烯酶的阳性率。
J Korean Med Sci. 2020 Sep 14;35(36):e303. doi: 10.3346/jkms.2020.35.e303.

引用本文的文献

1
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023.2010 - 2023年加拿大急症护理机构中产碳青霉烯酶肠杆菌科细菌的流行病学演变
Antimicrob Resist Infect Control. 2025 Jul 12;14(1):88. doi: 10.1186/s13756-025-01602-w.
2
Occurrence and Characteristics of Carbapenem-Resistant Strains Isolated from Hospitalized Patients in Poland-A Single Centre Study.波兰一家单中心研究:从住院患者中分离出的耐碳青霉烯类菌株的发生情况及特征
Pathogens. 2022 Jul 29;11(8):859. doi: 10.3390/pathogens11080859.

本文引用的文献

1
Hospitalization costs for patients colonized with carbapenemase-producing Enterobacterales during an Australian outbreak.澳大利亚暴发疫情期间产碳青霉烯酶肠杆菌科定植患者的住院费用。
J Hosp Infect. 2020 Jun;105(2):146-153. doi: 10.1016/j.jhin.2020.03.009. Epub 2020 Mar 13.
2
The effectiveness of alcohol-based gel for hand sanitising in infection control.酒精基凝胶在感染控制中用于手部消毒的有效性。
Br J Nurs. 2018 Apr 12;27(7):382-388. doi: 10.12968/bjon.2018.27.7.382.
3
Carbapenemase-Producing Organisms: A Global Scourge.产碳青霉烯酶的生物体:全球的祸害。
Clin Infect Dis. 2018 Apr 3;66(8):1290-1297. doi: 10.1093/cid/cix893.
4
Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant into healthcare settings: guidance from the European Centre for Disease Prevention and Control.预防耐碳青霉烯类进入医疗机构的感染预防与控制措施及工具:欧洲疾病预防控制中心指南
Antimicrob Resist Infect Control. 2017 Nov 15;6:113. doi: 10.1186/s13756-017-0259-z. eCollection 2017.
5
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.耐碳青霉烯类肠杆菌科细菌的流行病学:一种全球威胁的影响与演变
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36. doi: 10.1093/infdis/jiw282.
6
Carbapenemase-producing : Risk factors for infection and impact of resistance on outcomes.产碳青霉烯酶:感染的危险因素及耐药性对结局的影响。
Int J Appl Basic Med Res. 2017 Jan-Mar;7(1):32-39. doi: 10.4103/2229-516X.198520.
7
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.产碳青霉烯酶肺炎克雷伯菌和大肠埃希菌在欧洲产碳青霉烯酶肠杆菌科的调查(EuSCAPE)中的发生:一项前瞻性、多国研究。
Lancet Infect Dis. 2017 Feb;17(2):153-163. doi: 10.1016/S1473-3099(16)30257-2. Epub 2016 Nov 18.
8
Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?碳青霉烯类耐药肠杆菌科的筛查:谁、何时以及如何筛查?
Virulence. 2017 May 19;8(4):417-426. doi: 10.1080/21505594.2016.1255381. Epub 2016 Nov 4.
9
Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.耐碳青霉烯类肠杆菌科细菌:生物学、流行病学及管理
Ann N Y Acad Sci. 2014 Sep;1323:22-42. doi: 10.1111/nyas.12537.
10
Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.运用美国疾病控制与预防中心2012年耐碳青霉烯类肠杆菌科细菌工具包中所倡导的干预措施,控制重症监护病房内产碳青霉烯酶肠杆菌科细菌和广泛耐药鲍曼不动杆菌感染的同时暴发。
Infect Control Hosp Epidemiol. 2014 Jul;35(7):810-7. doi: 10.1086/676857. Epub 2014 May 15.